The addition of neoadjuvant pertuzumab for the treatment of HER2+ breast cancer: a cost estimate with real-world data (2021)
Article in International Scientific Journal
Borges, A; Pereira, F; Redondo, P; Antunes, L; Vieira, C; Antunes, P; Bento, MJ; Sousa, S; Lopes, JM; Gonçalves F; de Sousa, JA; Pereira, DS; Borges, M